Lifestyle Intervention for Pakistani Women in Oslo (InnvaDiab)

June 24, 2014 updated by: Gerd Holmboe-Ottesen, University of Oslo

Evaluation of a Lifestyle Intervention to Prevent Type 2 Diabetes/Metabolic Syndrome Among Pakistani Immigrants - Focusing on Changes in Diet and Physical Activity

Immigrants from South Asia in Norway have a high prevalence of type 2 diabetes and conditions related to the metabolic syndrome. It has been documented that these conditions may be prevented by changes in lifestyle. No previous intervention studies on immigrants with focus on diet and physical activity have been carried out in Norway. This project concerns a randomized controlled trial with intervention to change diet and physical activity in 200 high risk female Pakistani immigrants living in Oslo. The intervention will be evaluated both in terms of outcome and process.

Study Overview

Detailed Description

Objectives:

  1. To evaluate the health effects of systematic dietary education and counselling and physical training in a group of Pakistani women with high risk of type 2 diabetes.
  2. To evaluate the intervention process in order to identify the most effective methods of intervention in regard to diet and physical activity for immigrant women of Pakistani origin.

Background: Immigrants from South Asia have a high prevalence of type 2 diabetes, which may be prevented by intensive on physical activity and diet. This application concerns intervention with diet and physical activity in female (ongoing study) and male (extended study) Pakistani immigrants living in Oslo to reduce their risk for these diseases.

Intervention design: The subjects will be 200 women randomized into an intervention group and a control group (100 in each). The women are being recruited from a township in Oslo with a high proportion of immigrants by using a network approach. Inclusion criteria is based on a risk score developed by Ramachandran et al for Asian Indians, entailing age, Body Mass Index, waist circumference, family history of diabetes and sedentary physical activity.

The intervention will include a combination of individual counselling and group sessions. The intervention group will be divided into subgroups of 10-12 subjects. Each subgroup will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a cultural adapted exercise program of low intensity twice a week. This includes indoor activities (exercise with music) and outdoor activities (walking groups).

Evaluation: The main end point of the intervention will be the fasting and 2-h plasma glucose value after an oral glucose tolerance test (OGTT). This will be measured at baseline and after 6 months of intervention.

Secondary end-points will be Serum lipid profile (e.g. triglycerides, High-Density Lipoprotein-cholesterol) ; HbA1c ; C-peptide ; serum insulin; serum albumin; body weight; waist and hip circumference; maximum heart rate on treadmill test; self-reported level of intensity, duration and frequency of physical activity; self-reported level of "Stages of change" in regard to motivation and behavioural change; self- reported subjective health complaints; self-reported coping strategies; self-reported sleeping habits.

Dietary information will be collected by 2 x 48 hours dietary recalls. The intake of energy and nutrients will be calculated from the recalls, as well as the intake of food groups.The diet will also be evaluated by a culturally adapted food frequency questionnaire including 20 food groups (with portion sizes). In addition, the use of cooking oils will be registered by questions about the type and quantity oil used per time unit in the household. Additionally, information on knowledge and perceptions on diet and health before and after the intervention will be registered.

Physical activity will be registered using an advanced continuous body monitor, SenseWear Armband yielding information on total energy expenditure, level of intensity, duration and frequency of physical activity, duration of lying down, duration of sleeping, and sleeping quality.

The completion of the questionnaires will take the form of an interview by Urdu speaking staff.

Study Type

Interventional

Enrollment (Actual)

198

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Holmlia, Oslo
      • Oslo, Holmlia, Oslo, Norway, 1255
        • Primary Health Care Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Risk score developed by Ramachandran et al for Asian Indians:

    • BMI, waist circumference, family history of diabetes and sedentary physical activity

Exclusion Criteria:

  • Type 1 diabetes.
  • Positive auto antibodies.
  • Diagnosis of type 2 diabetes more than 6 months.
  • Medication for type 2 diabetes.
  • Pregnancy at intervention start.
  • Suffering from heart attack or stroke the last 3 months.
  • Already participating in organised physical exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention group was divided into nine subgroups of ten to twelve women who were offered six educational sessions, each lasting 2 h, during a 7 +- 1-month period. The main focus was on the physiological importance of blood glucose and its regulation by diet and physical activity, and on knowledge about the Pakistani lifestyle in Pakistan and Norway
The intervention will include a combination of individual counselling group sessions. The intervention groups will be divided into subgroups of 10-12 subjects. Each group will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a culturally adapted exercise program of low intensity twice a week.
No Intervention: Control
One lesson recieved after post-test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Fasting Plasma Glucose Value, Baseline
Time Frame: baseline
baseline
Plasma Glucose 2 h After Oral Glucose Tolerance Test, Baseline
Time Frame: baseline
baseline
The Fasting Plasma Glucose, Post-test
Time Frame: post-test
post-test
Plasma Glucose, 2-h, Post-test
Time Frame: post-test
post-test

Secondary Outcome Measures

Outcome Measure
Time Frame
HbA1c, Baseline
Time Frame: baseline
baseline
C-peptide, 0-h, Baseline
Time Frame: baseline
baseline
C-peptid, 2-h, Baseline
Time Frame: baseline
baseline
Insulin, 0-h, Baseline
Time Frame: baseline
baseline
Insulin, 2-h, Baseline
Time Frame: baseline
baseline
High-Density Lipoprotein Cholesterol, Baseline
Time Frame: baseline
baseline
Triglycerides, Baseline
Time Frame: baseline
baseline
Systolic Blood Pressure, Baseline
Time Frame: baseline
baseline
Diastolic Blood Pressure, Baseline
Time Frame: baseline
baseline
Waist Circumference, Baseline
Time Frame: baseline
baseline
Body Mass Index, Baseline
Time Frame: baseline
baseline
Intake of Vegetables, Fruit and Fruit Juice, Baseline
Time Frame: baseline
baseline
Intake of Soft Drinks With Added Sugar, Baseline
Time Frame: baseline
baseline
Intake of Red Meat, Baseline
Time Frame: baseline
baseline
Intake of Poultry, Baseline
Time Frame: baseline
baseline
Intake of Fish, Baseline
Time Frame: baseline
baseline
HbA1C, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 0-h, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
C-peptid, 2-h, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 0-h, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Insulin, 2-h, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
High-Density Lipoprotein Cholesterol, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Triglycerides, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Systolic Blood Pressure, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Diastolic Blood Pressure, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Waist Circumference
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Body Mass Index, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Vegetables, Fruit and Fruit Juice, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Soft Drinks With Added Sugar, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Red Meat, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Poultry, Post-test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions
Intake of Fish, Post Test
Time Frame: post-test, after completion of all six group sessions
post-test, after completion of all six group sessions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerd Holmboe-Ottesen, Dr. Philos., University of Oslo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2006

Primary Completion (Actual)

September 1, 2008

Study Completion (Actual)

September 1, 2008

Study Registration Dates

First Submitted

January 19, 2007

First Submitted That Met QC Criteria

January 19, 2007

First Posted (Estimate)

January 22, 2007

Study Record Updates

Last Update Posted (Estimate)

July 21, 2014

Last Update Submitted That Met QC Criteria

June 24, 2014

Last Verified

April 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on lifestyle intervention (diet and physical activity)

3
Subscribe